Reliably detects present Covid-19 infection in 15 minutes using a non-invasive sputum sample with an average accuracy rating of 98.5%*.
How this Rapid Antigen Detection Kit works
This new Rapid Antigen sputum sample lateral flow test is simple to use. It takes seconds to get the sputum sample and gives you results in just 15 minutes. All without the need to send anything to the lab.
Covguard provides a range of rapid lateral flow antigen tests from leading manufacturers. Tests can be conducted using either a simple non-invasive sputum sample as described here or using the traditional nose/throat swab sample method following the link below.Rapid COVID-19 Antigen Test - 15 min Nose/Throat Swab Test - Lateral Flow
With the advent of new technology sputum samples can now provide a more certain method of collecting a reasonable quantity of the virus in the sample when compared to a nose/throat swab sample.
Taking a nose/throat swab sample can be more difficult and uncomfortable particularly in certain groups.
How it Works
Our COVID-19 Antigen (Ag) Rapid Test is a self-contained, sample collection device, lateral flow chromatographic immunoassay for the detection of SARSCoV-2 (COVID-19) viral (nucleoprotein) antigens in sputum samples.
Our test kits are packaged for professional use and can be purchased as single test kits or in cartons containing 25 Single Test kits.
Each single test kit contains: Test card/lateral flow cassette, disposable sample extraction tube, cotton swab, disposable paper cup, instructions for use leaflet.
This is a simple and easy to use test for trained professionals. Unlike PCR testing our Rapid Antigen Tests do not require specialised laboratory personnel or instruments.
CE IVD marked.
Store between 2-30 0 C
This test is "for business or healthcare professional use only"
Please open an account to explore pricing options or please contact email@example.com for bulk purchase arrangements or to organise a bespoke testing service for your organisation.
•The clinical sensitivity of test reagent is 97.6%, the clinical specificity is 99.4% and the total agreement rate is 98.5% – based on 538 swab samples, Nov. 2020